Active Vitamin D, Global Key Players Rank and Market Share, Top Five Companies Hold 64.2% (2022) (Internet Services - Other Internet Services)
USAOnlineClassifieds > Internet Services > Other Internet Services
Item ID 2595929 in Category: Internet Services - Other Internet Services
Active Vitamin D, Global Key Players Rank and Market Share, Top Five Companies Hold 64.2% (2022) | |
Vitamin D3 itself has no physiological activity. It needs to be hydroxylated by 25-hydroxylase in the liver to form 25(OH)D, which is calcifediol, and then hydroxylated by 1α-hydroxylase in the kidney to form 1, 25-(OH)2D3, calcitriol, can exert its physiological regulatory function. Therefore, calcifediol and calcitriol are called the active forms of vitamin D, that is, active vitamin D. According to the new market research report “Global Active Vitamin D Market Report 2023-2029”, published by QYResearch, the global Active Vitamin D market size is projected to reach USD 6.18 billion by 2029, at a CAGR of 10.5% during the forecast period. According to QYResearch Top Players Research Center, the global key manufacturers of Active Vitamin D include Nanjing Haijing Pharmaceutical, Shandong Xinshidai, SICHUAN KELUN PHARMACEUTICAL, China Resources Double-crane Pharmaceutical, Taifeng, Jiangsu Hengrui Pharmaceuticals, Chongqing Huapont Shengchem Pharmaceutical, Chengdu Gowell Biopharmaceutial, Nanjing Heron Pharmaceutical Science And Technology, Genzyme Corporation, etc. In 2022, the global top five players had a share approximately 64.2% in terms of revenue. At present, the global core manufacturers are mainly distributed in Europe and China. Market Drivers: Active vitamin D is widely used in clinical practice. For elderly patients with osteoporosis (OP) and pregnancy/lactation related OP and decreased bone mineral density (BMD) who have gradually declined liver and kidney function, accompanied by sarcopenia and/or neurological damage, appropriate supplementation can be provided. The combination of active vitamin D and calcium supplements is the preferred treatment for hypoparathyroidism and osteomalacia, and is also one of the main measures for preventing and treating secondary hyperparathyroidism in patients with chronic kidney disease mineral and bone abnormalities. For more information, please contact the following e-mail address: Email: global@qyresearch.com Website: https://www.qyresearch.com QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 16 years’ experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 60,000 clients across five continents. Let’s work closely with you and build a bold and better future.  | |
| Target State: All States Target City : All Cities Last Update : Apr 14, 2024 10:27 PM Number of Views: 106 | Item Owner : Joyce Contact Email: Contact Phone: 13051817187 |
| Friendly reminder: Click here to read some tips. | |
USAOnlineClassifieds > Internet Services > Other Internet Services
© 2024 USAOnlineClassifieds.com
USNetAds.com | GetJob.us | CANetAds.com | UKAdsList.com | AUNetAds.com | INNetAds.com | CNNetAds.com | Hot-Web-Ads.com
2024-12-22 (0.576 sec)